Effect of Estrogen and Antiestrogens on Cell Proliferation and Synthesis of Secreted Proteins in the Human Breast Cancer Cell Line MCF-7 and a Tamoxifen Resistant Variant Subline, AL-1

References

• De Larco J E, Todaro G J. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci USA 1978; 75: 4001–5
   PubMed Web of Science ®Google Scholar
• Sirbasku D A. New concepts in control of estrogen-responsive tumor growth. Hormones and Cancer 1981; 425–43, Banbury Report 8
   Google Scholar
• Dickson R B, Thompson E W, Lippman M E. Regulation of proliferation, invasion and growth factor synthesis in breast cancer by steroids. J Steroid Biochem Mol Biol 1990; 37: 305–16
   PubMed Web of Science ®Google Scholar
• Osborne C K, Arteaga C L. Autocrine and paracrine growth regulation of breast cancer: Clinical implications. Breast Cancer Res Treat 1990; 15: 3–11
   PubMedGoogle Scholar
• Vignon F, Capony F, Chambon M, Freiss G, Garcia M, Rochefort H. Autocrine growth stimulation of the MCF-7 breast cancer cells by the estrogen-regulated 52 K protein. Endocrinol 1986; 118: 1537–45
   PubMed Web of Science ®Google Scholar
• Karey K P, Sirbasku D A. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and l7β-estradiol. Cancer Res 1988; 48: 4083–92
   PubMed Web of Science ®Google Scholar
• Van der Burg B, Isbrücker L, van Selm-Miltenburg A JP, de Laat S W, van Zoelen E JJ. The role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. Cancer Res 1990; 50: 7770–4
   PubMed Web of Science ®Google Scholar
• Arteaga C L, Osborne C K. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 1989; 49: 6237–41
   PubMed Web of Science ®Google Scholar
• Arteaga C L, Kitten L J, Coronado E B, Jacobs S, Kull F C. Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice. J Clin Invest 1989; 84: 1418–23
   PubMed Web of Science ®Google Scholar
• Van der Burg B, van Selm-Miltenburg A JP, de Laat S W, van Zoelen E JJ. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells. Mol Cell Endocrinol 1989; 64: 223–8
   PubMedGoogle Scholar
• Lippman M E, Dickson R B, Gelmann E P, et al. Growth regulation of human breast cancinoma occurs through regulated growth factor secretion. J Cell Biochem 1987; 35: 1–16
   PubMed Web of Science ®Google Scholar
• Sheen Y Y, Katzenellenbogen B S. Antiestrogen stimulation of the production of a 37 000 molecular weight secreted protein and estrogen stimulation of the production of a 32 000 molecular weight secreted protein in MCF-7 human breast cancer cells. Endocrinol 1987; 120: 1140–51
   PubMedGoogle Scholar
• Lykkesfeldt A E, Laursen I, Briand P. Regulation of the secretion of proteins synthesized by the human breast cancer cell line, MCF-7. Mol Cell Endocrinol 1989; 62: 287–96
   PubMedGoogle Scholar
• Lykkesfeldt A E, Laursen I, Briand P. (1991) The role of estrogen regulated secreted proteins for growth regulation of human breast cancer. In: Breast Cancer: Biological and Clinical Progress. Proceedings of the International Association for Breast Cancer Research Conference, St VincentItaly, May, 1991. Kluwer Academic Publisher
   Google Scholar
• Chalbos D, Vignon F, Keydar I, Rochefort H. Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line T47D. J Clin Endocrinol Metab 1982; 55: 276–83
   PubMed Web of Science ®Google Scholar
• Edwards D P, Chamness G C, McGuire W L. Estrogen and progesterone receptor proteins in breast cancer. Biochim Bio-phys Acta 1979; 560: 457–86
   PubMedGoogle Scholar
• Rose C, Thorpe S M, Lsber J, Dæhnfeldt J L, Palshof T, Mouridsen H T. Therapeutic effect of tamoxifen related to estrogen receptor level. Recent Results Cancer Res 1980; 71: 134–41
   PubMedGoogle Scholar
• Westley B, Rochefort H. Estradiol induced proteins in the MCF-7 human breast cancer cell line. Biochem Biophys Res Commun 1979; 90: 410–6
   PubMedGoogle Scholar
• Jordan V C. Long-term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Res Treat 1990; 15: 125–36
   PubMed Web of Science ®Google Scholar
• Sonnenschein C, Papendorp J T, Soto A M. Estrogenic effect of tamoxifen and its derivatives on the proliferation of MCF-7 human breast tumor cells. Life Sci 1985; 37: 387–94
   PubMedGoogle Scholar
• Horwitz K B, Koseki Y, McGuire W L. Estrogen control of progesterone receptor in human breast cancer: Role of estradiol and antiestrogen. Endocrinol 1978; 103: 1742–51
   PubMed Web of Science ®Google Scholar
• May F EB, Westley B R. Effects of tamoxifen and 4-hydroxy-tamoxifen on the pNR-1 and pNR-2 estrogen-regulated RNAs in human breast cancer cells. J Biol Chem 1987; 262: 15894–9
   PubMedGoogle Scholar
• Wakeling A E, Bowler J. Biology and mode of action of pure antioestrogens. J Steroid Biochem 1988; 30: 141–7
   PubMedGoogle Scholar
• Wakeling A E. Novel pure antiestrogens. Mode of action and therapeutic prospects. Ann NY Acad Sci 1990; 595: 348–58
   PubMedGoogle Scholar
• Wakeling A E. Therapeutic potential of pure antioestrogens in the treatment of breast cancer. J Steroid Biochem Mol Biol 1990; 37: 771–5
   PubMedGoogle Scholar
• Lykkesfeldt A E, Briand P. Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines. Br J Cancer 1986; 53: 29–35
   PubMed Web of Science ®Google Scholar
• Briand P, Lykkesfeldt A E. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. Cancer Res 1984; 44: 1114–9
   PubMed Web of Science ®Google Scholar
• Thorpe S M, Lykkesfeldt A E, Vinterby A, Lonsdorfer M. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies. Cancer Res 1986; 46(Suppl)4251s–5s
   Google Scholar
• Lippman M, Bolan G, Huff K. The effect of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976; 36: 4595–601
   PubMed Web of Science ®Google Scholar
• Darbre P, Yates J, Curtis S, King R JB. Effect of estradiol on human breast cancer cells in culture. Cancer Res 1983; 43: 349–54
   PubMed Web of Science ®Google Scholar
• Van der Burg B, Rutteman G R, Blankenstein M A, de Laat S W, van Zoelen E JJ. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 1988; 134: 101–8
   PubMedGoogle Scholar
• Laursen I, Briand B, Lykkesfeldt A E. Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res 1990; 10: 343–52
   PubMed Web of Science ®Google Scholar
• Wakeling A E, Dukes M, Bowler J. A potent specific pure antiestrogen with clinical potential. Cancer Res 1991; 51: 3867–73
   PubMed Web of Science ®Google Scholar
• Wakeling A E. Comparative studies on the effects of steroidal and nonsteroidal oestrogen antagonists on the proliferation of human breast cancer cells. J Steroid Biochem 1989; 34: 183–8
   PubMedGoogle Scholar
• Thompson E W, Katz D, Shima T B, Wakeling A E, Lippman M E, Dickson R B. ICI 164,384 a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res 1989; 49: 6929–34
   PubMed Web of Science ®Google Scholar
• Wiseman L R, Wakeling A E, May F EB, Westley B R. Effects of the antioestrogen, ICI 164,384, on oestrogen induced RNAs in MCF-7 cells. J Steroid Biochem 1989; 33: 1–6
   PubMedGoogle Scholar
• Mullick A, Chambon P. Characterization of the estrogen receptor in two antiestrogen-resistant cell lines, LY2 and T47D. Cancer Res 1990; 50: 333–8
   PubMed Web of Science ®Google Scholar
• Pasqualini J R, Giambiagi N, Gelly C, Chetrite G. Antiestrogen action in mammary cancer and in fetal cells. J Steroid Biochem Mol Biol 1990; 37: 343–8
   PubMedGoogle Scholar
• Lykkesfeldt A E, Larsen J K, Christensen I J, Briand P. Erects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7. Br J Cancer 1984; 49: 717–22
   PubMedGoogle Scholar
• Weatherill P J, Wilson A PM, Nicholson R I, Wakeling P., Davies A E. Interaction of the antioestrogen ICI 164.384 with the oestrogen receptor. J Steroid Biochem 1988; 30: 1–6
   Google Scholar
• Nicholson R I, Syne J S, Daniel C P, Griffiths K. The binding of tamoxifen to oestrogen receptor proteins under equilibrium and non-equilibrium conditions. Eur J Cancer 1979; 15: 317–29
   PubMed Web of Science ®Google Scholar
• Coezy E, Borgna J L, Rochefort H. Tamoxifen and metabolites in MCF-7 cells: Correlation between binding to estrogen receptor and inhibition of cell growth. Cancer Res 1982; 42: 317–23
   PubMed Web of Science ®Google Scholar
• Wilson A PM, Weatherill P J, Nicholson R I, Davis P., Wakeling A E. A comparative study of the interaction of oestradiol and the steroidal pure antioestrogen, ICI 164,384, with the mobybdate-stabilized oestrogen receptor. J Steroid Biochem 1990; 35: 421–8
   PubMedGoogle Scholar
• Knabbe C, Lippman M E, Wakefield L M, et al. Evidence that transforming growth factor-p is a hormonally regulated negative growth factor in human breast cancer cells. Cell 1987; 48: 417–28
   PubMed Web of Science ®Google Scholar
• Lykkesfeldt A E, Rose C, Thorpe S M, Laursen I, Lykkesfeldt G, Briand P. Oestrogen reversible inhibitory activity of sera from breast cancer patients. Eur J Cancer Clin Oncol 1988; 24: 1647–53
   PubMedGoogle Scholar
• Johnson M D, Westley B R, May F EB. Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells. Br J Cancer 1989; 59: 727–38
   PubMedGoogle Scholar
• Green S. Modulation of oestrogen receptor activity by oestrogens and anti-oestrogens. J Steroid Biochem Mol Biol 1990; 37: 747–51
   PubMedGoogle Scholar